It also showed that NOX5‐produced reactive oxygen species (ROS) activated several oncogenic signaling pathways, indicating that NOX5 may serve as a target for ESCC diagnosis and treatment.17 This evidence concerns the gene NOX5 and esophageal squamous cell carcinoma.